Innoviva (INVA) Gross Margin (QoQ) (2011 - 2026)

Innoviva (INVA) Gross Margin (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Innoviva 1.54 Bn 968.79 Mn 90.62 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -397,081.00
Sep 30, 2025 -472.00
Jun 30, 2025 19.00
Sep 30, 2024 -337.00
Jun 30, 2024 -232,423.00
Sep 30, 2023 31,690.00
Jun 30, 2023 -23,099.00
Sep 30, 2022 -139.00
Jun 30, 2022 0.00
Dec 31, 2011 0.00
Sep 30, 2011 1,842.00